Stay updated with breaking news from Ischemic Stroke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Further details from the phase 2b AZALEA trial of the factor XI inhibitor abelacimab show significant reductions in major and clinically relevant nonmajor bleeding vs rivaroxaban for patients with AF.
Further analyses from the ARTESIA study and the previous NOAH-AFNET 6 trial are needed to try to identify groups where the benefit may outweigh the risk, researchers say.
A neurologic music therapy intervention reduces depression and increases neuroplasticity in stroke patients, pilot results suggest.
The association between three clinical BA measures and neurological disease risk.
People who live in neighborhoods with lower socioeconomic status are less likely to receive clot-busting medications or undergo clot-removing procedures after they have a stroke than people who live in neighborhoods with higher socioeconomic status, according to a study published in the November 1, 2023, online issue of Neurology, the medical journal of the American Academy of Neurology.